Latest Breaking News On - Optimus pharma - Page 6 : comparemela.com

Molnupiravir shows promising results in phase 3 trials: Optimus Pharma

Molnupiravir shows promising results in phase 3 trials: Optimus Pharma
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

D srinivasa reddyOptimus pharmaManaging directorDrugs controller generalட ஸ்ரீநிவாச சிவப்புஉகந்த பார்மாநிர்வகித்தல் இயக்குனர்மருந்துகள் கட்டுப்படுத்தி ஜநரல்

The league of little-known companies that stepped up to make Covid-19 drugs and vaccines

The league of little-known companies that stepped up to make Covid-19 drugs and vaccines
thehindubusinessline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindubusinessline.com Daily Mail and Mail on Sunday newspapers.

Tamil naduSun pharmaDharwad karnatakaTarun kediaJyothi dattaOptimus pharmaPune brinton pharmaceuticalsLife sciencesBrinton pharmaceuticalsBrinton chairmanManaging directorWest bengalBesides optimusLasa supergenericsShilpa medicareதமிழ் நாடு

Pharmaceutical Companies Sued Over Generic Parkinson s Medication

A host of pharmaceutical companies are under suit over allegations of patent infringement after they all filed Abbreviated New Drug Applications (ANDAs)

Prinston pharmaceutical incNewron pharmaceuticalsAurobindo pharma united states incOptimus pharmaZenara pharma privateMdd us operationsRk pharma incLaboratories privateAurobindo pharmaAbbreviated new drug applicationsAurobindo pharma limitedPrivate limitedPrinston pharmaceuticalZenara pharma private limitedஅரவிந்தோ பார்மா ஒன்றுபட்டது மாநிலங்களில் இன்க்உகந்த பார்மா

Optimus Pharma gets DCGI nod for conducting Phase III Clinical Trials for Molnupiravir on patients with mild to moderate COVID-19

Hyderabad (Telangana) [India], May 25 (ANI/PRNewswire): Optimus Pharma on the 19th of May 2021 received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild to Moderate Covid-19 patients. With severe shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced. Optimus Pharma said having internally developed the active pharmaceutical ingredient (API) and the formulations for the product, it had filed for clinical trials with the DCGI. The regulator gave nod for conducting the trial on mild to moderate patients.

Drd srinivas reddyOptimus pharmaExpert committeeManaging directorSubject expert committeeDrd srinivas reddyOptimus pharmaClinical trialsட ஸ்ரீநிவாஸ் சிவப்புஉகந்த பார்மாநிபுணர் குழுநிர்வகித்தல் இயக்குனர்பொருள் நிபுணர் குழு

Drugs manufacturer from Hyderabad on overdrive

Drugs manufacturer from Hyderabad on overdrive ANI | Updated: May 19, 2021 13:15 IST Hyderabad (Telangana) [India], May 19 (ANI/PNN): Optimus Pharma on Tuesday received DCGI nod for conducting Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild and Moderate Covid-19 symptoms. With a severe shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced. Optimus pharma said having internally developed the active pharmaceutical ingredient (API) and the formulations for the product, it had filed for clinical trials with the DCGI. The regulator gave a nod for conducting the trial on mild and moderate patients on May 18 2021.

Drd srinivas reddyOptimus pharmaExpert committeeManaging directorSubject expert committeeDrd srinivas reddyOptimus pharmaட ஸ்ரீநிவாஸ் சிவப்புஉகந்த பார்மாநிபுணர் குழுநிர்வகித்தல் இயக்குனர்பொருள் நிபுணர் குழு